Search Medical Condition
Please enter condition
Please choose location from dropdown
Clear Trial Filters
 

Charlotte, North Carolina Clinical Trials

A listing of Charlotte, North Carolina clinical trials actively recruiting patient volunteers.

RESULTS

Found (5) clinical trials

DE-117 Spectrum 5 Study

Santen will evaluate the intraocular pressure (IOP) lowering effect and efficacy of DE-117 ophthalmic solution 0.002% in latanoprost/non-responder subjects diagnosed with POAG or OHT

Phase

3.4 miles

Learn More »

A Study of Subcutaneous Nivolumab Monotherapy With or Without Recombinant Human Hyaluronidase PH20 (rHuPH20)

The purpose of this study is to investigate the effects of nivolumab when given under the skin with or without rHuPH20. This study will include participants with 1 of the following advanced or metastatic tumors approved for treatment with nivolumab monotherapy: non-small cell lung cancer (NSCLC) renal cell carcinoma (RCC) ...

Phase

3.4 miles

Learn More »

Tinostamustine Conditioning and Autologous Stem Cell

Study Design (Methodology): This is a 2-part, international, multi-center, open-label study of salvage treatment with tinostamustine conditioning followed by ASCT in patients with relapsed/ refractory multiple myeloma (MM). (ASCT is defined as salvage if the patient had already received a prior ASCT and undergoes a second ASCT after evidence of ...

Phase

3.4 miles

Learn More »

A research study is evaluating an investigational vaccine for Respiratory Syncytial Virus (RSV) in healthy adults.  

Phase N/A

6.27 miles

Learn More »

A Phase III Study Assessing the Efficacy and Safety of DE-117 Ophthalmic Solution Compared With Timolol Maleate Ophthalmic Solution 0.5% in Subjects With Glaucoma or Ocular Hypertension - Spectrum 3 Study

This is a Phase III, randomized, double-masked, active-controlled, parallel-group, multi-center study. Subjects diagnosed with glaucoma or OHT who meet eligibility criteria at Visit 1 (Screening) will washout of their current topical IOP-lowering medication(s), if any. After completing the required washout period, subjects will return for Visit 2 (Baseline, Day 1). ...

Phase

9.37 miles

Learn More »